Some ATTR-ACT related medicinal chemistry. Dr. Evan Powers showing us how he designed the molecule that became tafamidis, at the bottom, based on the observation that resveratrol binds to transthyretin. We’re incredibly excited that work from our lab is benefiting patients.

My open letter to Dr. Stephen M. Hahn medscape.com/viewarticle/93… Medscape

Awesome Back To School Night! #LoveSDSchools